Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 26 Sep 24 424B4 Prospectus supplement with pricing info
- 26 Sep 24 EFFECT Notice of effectiveness
- 25 Sep 24 S-1/A IPO registration (amended)
-
18 Sep 24 S-1/A IPO registration (amended)
- 3 Sep 24 S-1 IPO registration
BIOA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated May 31, 2024, except for the effects of the reverse stock split discussed in Note 12E, as to which the date is September 18, 2024, with respect to the consolidated financial statements of BioAge Labs, Inc., included herein, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Francisco, California
September 18, 2024